Insulin initiation and intensification in patients with T2DM for the primary care physician
Jeff UngerCatalina Research Institute, Chino, CA, USAAbstract: Type 2 diabetes mellitus (T2DM) is characterized by both insulin resistance and inadequate insulin secretion. All patients with the disease require treatment to achieve and maintain the target glycosylated hemoglobin (A1C) level of 6.5%&...
Main Author: | Unger J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-06-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/insulin-initiation-and-intensification-in-patients-with-t2dm-for-the-p-a7749 |
Similar Items
-
Initiation and intensification of insulin therapy in type 2 diabetes mellitus: Physician barriers and solutions – An Indian perspective
by: Viswanathan Mohan, et al.
Published: (2021-09-01) -
Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis
by: E. V. Biryukova, et al.
Published: (2017-11-01) -
Association of initiation of basal insulin analogues V/S NPH insulin with hypoglycemia related emergency department visits or hospital admissions and with glycemic control in patients with type 2 DM
by: Kasia J Lipska, et al.
Published: (2019-01-01) -
Association Analysis of Insulin Resistance and Osteoporosis Risk in Chinese Patients with T2DM
by: Wang X, et al.
Published: (2021-08-01) -
Management of T1DM in children and adolescents in primary care
by: Norzaihan Hassan, et al.
Published: (2017-08-01)